Invention Grant
- Patent Title: Methods for synthesizing anticoagulant polysaccharides
-
Application No.: US17376354Application Date: 2021-07-15
-
Publication No.: US11542534B2Publication Date: 2023-01-03
- Inventor: Tarsis Ferreira Gesteira , Daniel H. Lajiness
- Applicant: OPTIMVIA, LLC
- Applicant Address: US OH Batavia
- Assignee: OPTIMVIA, LLC
- Current Assignee: OPTIMVIA, LLC
- Current Assignee Address: US OH Batavia
- Agency: Nesbitt IP LLC
- Agent Daniel H. Lajiness; Daniel F. Nesbitt
- Main IPC: C12P19/04
- IPC: C12P19/04 ; A61K31/727 ; C12N9/90 ; C12P19/26 ; C12P19/28 ; C08B37/00 ; C08J11/10 ; C12N9/10

Abstract:
The present invention includes methods for preparing anticoagulant polysaccharides using several non-naturally occurring, engineered sulfotransferase enzymes that are designed to react with aryl sulfate compounds instead of the natural substrate, PAPS, to facilitate sulfo group transfer to polysaccharide sulfo group acceptors. Suitable aryl sulfate compounds include, but are not limited to, p-nitrophenyl sulfate or 4-nitrocatechol sulfate. Anticoagulant polysaccharides produced by methods of the present invention comprise N-, 3-O-, 6-O-sulfated glucosamine residues and 2-O sulfated hexuronic acid residues, have comparable anticoagulant activity compared to commercially-available anticoagulant polysaccharides, and can be utilized to form truncated anticoagulant polysaccharides having a reduced molecular weight.
Public/Granted literature
- US20220010344A1 METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES Public/Granted day:2022-01-13
Information query